Ļć½¶Ö±²„

P. Hemachandra Reddy, Ph.D., is the Tenured Professor and Vice Chair of Research of Basic and Translational Sciences Internal Medicine and Professor of Pharmacology & Neuroscience, Neurology, Public Health, and Speech, Language, and Hearing Departments at Texas Tech University Health Sciences Center in Lubbock. Dr. Reddy is also an adjunct Professor of the Nutritional Sciences Department of Human Sciences at Texas Tech University, Lubbock.       

Dr. Reddyā€™s scientific accomplishments cover a spectrum of neurologic disorders, with an emphasis on the role of mitochondria in Alzheimerā€™s disease (AD). Over the past two decades, he has firmly earned an international reputation for his work in aging, AD, and mitochondrial research. He has already received notable peer recognition. In 2014 he was elected a Fellow of the American Neurological Association (ANA. In 2020 he was elected as a Fellow of the American Association for the Advancement of Science Fellowship (F-AAAS) in the Biological Sciences category, where he was specifically recognized for his contributions to the understanding of the role of mitochondria in neurodegenerative diseases and their therapeutic targeting. In 2023 he was elected to the Sigma Xi Society, an honor society that recognizes scientific excellence. On December 12, 2023, Dr. Reddy was elected to the National Academy Inventors Fellows (NAI). Academic inventors and innovators are nominated to the rank of NAI Fellow status by their peers for making outstanding contributions to innovation in areas such as patents and licensing, innovative discovery and technology, significant impact on society, and support and enhancement of innovation. 

Dr. Reddy has published three Books with Elsevier ā€“ 1) Molecular Biology of Aging in 2017, 2) COVID-19 in Alzheimerā€™s Disease and Dementia in 2023, and  3. Co-edited/Published ebook ā€˜Interphase Between Aging and Neurodegenerative Diseasesā€™, Published in 2020.

He was formerly an Executive Director and Chief Scientific Officer of the Garrison Institute on Aging (2014-2019) and a former Associate Scientist (2009-2014) in the Division of Neuroscience at the Oregon National Primate Research Center, affiliated with Oregon Health & Sciences University.

Dr. Reddy received his B.Sc. and M.Sc. in biology from Sri Venkateswara University, Tirupati, India, and he received an M. Phil in human cytogenetics from Delhi University. As a Commonwealth scholar (1990ā€“1993), he was awarded a PhD (1994) in human genetics from the University College, London. Dr. Reddy received postdoctoral training (1995-2000) at the National Human Genome Research Institute of the National Institutes of Health. He was a standing member of the Veteran Affairs Merit Review Study Section (2007-2010), NIH study section, Neuronal Oxidative Metabolism and Death (2013-2019), and served on several NIH study sections. He received funding from NIH in 2002. Dr. Reddy is the Co-inventor and Chief Scientific Officer of Lubbock-based small business company, abSynapTEX, LLC. Recently, abSynapTEX, LLC received an STTR award from NIH. 

Dr. Reddy is a prolific writer, author, or co-author of more than 270 peer-reviewed articles/chapters/reviews, including publications in such journals as Nature Genetics, Redox Biology, Aging Cell, Ageing Research Reviews, Trends in Neurosciences, Trends in Molecular Medicine, Drug Discovery Today and Human Molecular Genetics. As indicated on the Google Scholar website https://scholar.google.com/citations?view_op=list_works&hl=en&user=AfziV3YAAAAJ (Google Scholar search), Dr. Reddyā€™s articles have received over 30,000 citations with an H-Index of 89 and an i10-Index of 200.

According to Expertscape website (2023), the expertise of P. Hemachandra Reddy ranks in the Top 0.0081% of 259,115 published authors worldwide on Mitochondria from 2013 through 2023 https://expertscape.com/au/mitochondria/Reddy%2C+P+H According to  Stanford University Academic Ranking, Dr. Reddy has been on the Top 1.5% World Researchers and #1 at  Ļć½¶Ö±²„-GSBS and in 2021, Dr. Reddy received Ļć½¶Ö±²„ Presidentā€™s Excellence in Research Award. 

In addition, he received several awards and honors including the Prestigious Bharath Gaurav Award (2016) from the Government of India; the Best Mentor Award (2003) and Technology Innovation Award (2007) from Oregon Health and Science University and the Alzheimer's Award (2006) from the Journal of Alzheimer's Disease and Fellows Award for Research Excellence (FARE Award) (1999) from National Institutes of Health. Dr. Reddy was honored as best neuroscientist for his contributions to neurology and brain disorders at the second International conference, in Rome, Italy June 3-6, 2018. 

Dr. Reddy received three United States patents for his lab discoveries:  a) D-1289 - Aqua-soluble DDQ Promotes Healthy Aging and Delays Progression of Alzheimerā€™s Disease in Humans), b) D-1417 - MicroRNA-455-3p as a Potential Peripheral Biomarker for Alzheimerā€™s Disease and c) D-1535 - Identification of novel circulatory microRNA signatures linked to patients with Ischemic Stroke. Several others are pending d) Synaptosomal microRNAs and synapse functions in Alzheimerā€™s disease, e) D-1294 - Mitochondrial Division Inhibitor 1 for the Treatment of Alzheimerā€™s Disease), f) D-1417 - MicroRNA-455-3p as a Potential Peripheral Biomarker for Alzheimerā€™s Disease), g) D-2019-066 - Phosphorylated Tau Inhibitors for treatment of Alzheimer's Diseaseā€ disclosed 4/8/2019, and h) D-2020-060 - BACE1 Inhibitory Ligand Molecules against Amyloid Beta-induced Synaptic and Mitochondrial Toxicities. 

He served on several review panels and committees, outside the Ļć½¶Ö±²„, including:  a) Regular member of the NIH Neuronal Oxidative Metabolism and Death Study Section (2013-2019).  At Ļć½¶Ö±²„, he served as a - a) Member of the Ļć½¶Ö±²„ Faculty Development Leave Committee (2015-2018), b) Member and Chair of the SOM-Ļć½¶Ö±²„ Research Executive Committee (2016-2019), c) Member of the Ļć½¶Ö±²„ Medical Students Promotion Committee (2016-2019), d) Member of the University Research Council (2017-2018), and e) Member of the Ļć½¶Ö±²„ Post Tenure Committee (2018-2020).

Dr. Reddy supervised/mentored over 120 interns/students/postdoctoral fellows/junior faculty.  At least 10 of his postdoctoral fellows are faculty members and/or working in established pharmaceutical companies in the US and abroad. Most recently, Dr. Reddyā€™s postdoctoral Fellow Dr. Subodh Kumar received a 5-year Career Development Award from NIA/NIH. Dr. Reddy is also co-mentor for another postdoctoral fellow, Dr. Rebecca M. Parodi-RullĆ”n from Temple University who recently awarded her Career Development Award (July 1, 2023 to Jun 30, 2025 (K99). 

He trained over 25 medical students in the last 10 years at Ļć½¶Ö±²„, these students are authors and co-authors in high-impact factor journals and are matched at the best residency programs in the US. In 2020 alone, 6 medical students (years 1-3) worked with Dr. Reddy in conducting research in the lab and/or writing articles. The major focus of 2020 medical students' research was on COVID-19.  

Dr. Reddy strongly supports women in science and currently, the Reddy Lab has more women scientists than men scientists at all levels; postdoctoral scientists, technicians, students, and interns. We believe this is a wonderful accomplishment, and we recognize the need for more women in Science Technology, Engineering, and Mathematics (STEM). Reddy and his colleagues encourage and strongly support women in science. The Reddy lab is committed to ensuring flexibility and an encouraging environment for women in science. We ensure that our scientists can flex out to balance their work-life schedule as long they are happy and enjoy their work. Dr. Reddy and lab colleagues are proud to see a FIRST WOMEN PRESIDENT, Dr. Lori Rice-Spearman at Ļć½¶Ö±²„. 

He has over 24 years of research and leadership experience.  He enjoys teaching & researching neurological diseases and truly believes that in his lifetime, significant therapeutic developments will improve the lives of persons with neurological diseases and their caretakers.  Dr. Reddy also enjoys managing large organizations, which led to developing and maintaining a large network of colleagues in research, education, and government regulation. 

Dr. Reddy's research interests are ā€“ Drug Discovery, Healthy Aging, MicroRNAs, Synapse, Mitochondria, Oxidative Stress, Neurodegenerative Diseases including Alzheimer's, Huntington's Parkinson's, Multiple Sclerosis, Diabetes/Obesity, Multiple Sclerosis, Depression, Gender-based Studies, Biomarker Development, Bioinformatics and Gene Expression Analysis, and Animal models.